Roche and HYCOR Biomedical have signed a global distribution agreement for KOVA urinalysis products. Roche will distribute KOVA urinalysis plastics and controls products with its urinalysis tests and platforms worldwide for the next five years.
 
"Concurrent with our global leading position in in vitro diagnostics, the expanded agreement with HYCOR emphasizes our commitment of bringing industry expertise in providing high-quality urinalysis products to health professionals at hospital laboratories," said Colin Brown, head of Roche Professional Diagnostics.
 
"KOVA has been an industry-leader for more than 30 years, and we are pleased to partner with Roche to distribute this group of quality urinalysis products worldwide," said Dick Aderman, president and chief executive officer, HYCOR. "This agreement allows us to expand our presence into an additional 85 markets, further underscoring the value it brings to the healthcare professionals and patients it serves."